{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:01Z","timestamp":1786119241056,"version":"build-2736575974"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/bor.0b013e3283331151","type":"journal-article","created":{"date-parts":[[2009,11,22]],"date-time":"2009-11-22T03:26:20Z","timestamp":1258860380000},"page":"8-14","source":"Crossref","is-referenced-by-count":53,"title":["Recent progress in the genetics of Wegener's granulomatosis and Churg\u2013Strauss syndrome"],"prefix":"10.1097","volume":"22","author":[{"given":"Stefan","family":"Wieczorek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia U","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg T","family":"Epplen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty five patients","volume":"42","author":"Guillevin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutophil cytoplasmatic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sabl\u00e9-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical manifestations of antineutrophil antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0","article-title":"Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome","volume":"44","author":"Kiene","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","article-title":"Peripheral blood and granuloma CD4+ CD28\u2212 T-cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis","volume":"160","author":"Komocsi","year":"2002","journal-title":"Am J Pathol"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/art.23557","article-title":"Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission","volume":"58","author":"Abdulahad","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0140-6736(99)04206-3","article-title":"Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules","volume":"354","author":"Moins-Teisserenc","year":"1999","journal-title":"Lancet"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/art.23675","article-title":"HLA class I deficiency syndrome mimicking Wegener's granulomatosis","volume":"58","author":"Villa-Forte","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1016\/S0272-6386(00)70288-5","article-title":"A familial case of P-ANCA glomerulonephritis presenting in a father and daughter","volume":"35","author":"Hull","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R11-3-20210128","first-page":"618","article-title":"Familial vasculitides: Churg-Strauss syndrome and Wegener's granulomatosis in 2 first-degree relatives","volume":"30","author":"Manganelli","year":"2003","journal-title":"J Rheumatol"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/rheumatology\/kei261","article-title":"Two familial cases of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"45","author":"Rihova","year":"2006","journal-title":"Rheumatology"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/art.23157","article-title":"Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease","volume":"58","author":"Knight","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ng2046","article-title":"FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity","volume":"39","author":"Fanciulli","year":"2007","journal-title":"Nat Genet"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1084\/jem.20072413","article-title":"Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake","volume":"205","author":"Willcocks","year":"2008","journal-title":"J Exp Med"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides: proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1309\/WAEPADW0K4LPUHFN","article-title":"Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmatic antibodies: quality control guidelines, comments, and recommendations for testing in other autoimmune diseases","volume":"120","author":"Savige","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R20-3-20210128","first-page":"763","article-title":"ANCA against the bactericidal\/permeability increasing protein (BPI-ANCA) can compromise the antibiotic function of BPI in a Wegener's granulomatosis patient","volume":"21","author":"Schultz","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1744-313X.2005.00495.x","article-title":"Association study of Wegener granulomatosis and the functionally relevant A645G polymorphism in the bactericidal\/permeability increasing protein (BPI) gene","volume":"32","author":"Jagiello","year":"2005","journal-title":"Int J Immunogenet"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1046\/j.1523-1755.2000.00430.x","article-title":"Proteinase 3 gene polymorphisms and Wegener's granulomatosis","volume":"58","author":"Gencik","year":"2000","journal-title":"Kidney Int"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2249.2004.02608.x","article-title":"The -564 A\/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity","volume":"138","author":"Pieters","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2249.2006.03119.x","article-title":"Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the -564 A\/G promotor polymorphism","volume":"145","author":"Abdgawad","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1097\/01.ASN.0000028642.26222.00","article-title":"Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis","volume":"13","author":"Rarok","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ki.1993.186","article-title":"Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis","volume":"43","author":"Esnault","year":"1993","journal-title":"Kidney Int"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/16.1.39","article-title":"Analysis of antineutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects","volume":"16","author":"Audrain","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1182\/blood-2005-05-1875","article-title":"Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via protease-activated receptor-2 pathway","volume":"107","author":"Csernok","year":"2006","journal-title":"Blood"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","article-title":"Netting neutrophils in autoimmune small-vessel vasculitis","volume":"15","author":"Kessenbrock","year":"2009","journal-title":"Nat Med"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/clim.2002.5206","article-title":"-463G\/A Myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in ANCA associated vasculitis","volume":"103","author":"Reynolds","year":"2002","journal-title":"Clin Immunol"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/ndt\/gfh025","article-title":"No association of G-463A myeloperoxidase gene polymorphism with MPO\u2013ANCA-associated vasculitis","volume":"19","author":"Fiebeler","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2249.2007.03418.x","article-title":"Meta-analysis of myeloperoxidase G-463\/A polymorphism in antineutrophil cytoplasmic autoantibody-positive vasculitis","volume":"149","author":"Rajp","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00439-004-1092-z","article-title":"New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes","volume":"114","author":"Jagiello","year":"2004","journal-title":"Hum Genet"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/ard.2007.077693","article-title":"The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping","volume":"67","author":"Heckmann","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2350-7-21","article-title":"On the Wegener granulomatosis associated region on chromosome 6p21.3","volume":"7","author":"Szyld","year":"2006","journal-title":"BMC Med Genet"},{"key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/rheumatology\/kep057","article-title":"HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis","volume":"48","author":"Stassen","year":"2009","journal-title":"Rheumatology"},{"key":"R38-3-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2249.1999.00969.x","article-title":"Immunogenetic risk factors for antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis","volume":"117","author":"Gencik","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.22834","article-title":"HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome","volume":"56","author":"Vaglio","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.23209","article-title":"Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al.","volume":"58","author":"Wieczorek","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R41-3-20210128","first-page":"226","article-title":"Polymorphisms in the tumor necrosis factor genes in Wegener's granulomatosis","volume":"14","author":"Mascher","year":"1997","journal-title":"Exp Clin Immunogenet"},{"key":"R42-3-20210128","first-page":"397","article-title":"Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis","volume":"27","author":"Huang","year":"2000","journal-title":"J Rheumatol"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.20385","article-title":"An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's ranulomatosis","volume":"50","author":"Zhou","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/ard.2004.025809","article-title":"Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis","volume":"64","author":"Spriewald","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1744-313X.2006.00568.x","article-title":"Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups","volume":"3","author":"Akkad","year":"2006","journal-title":"Int J Immunogenet"},{"key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1002\/art.21487","article-title":"The PTPN22 620W allele is a risk factor for Wegener's granulomatosis","volume":"52","author":"Jagiello","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2249.2000.01182.x","article-title":"Neutrophil FcgammaRIIIb allelic polymorphism in antineutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis","volume":"119","author":"Tse","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"R48-3-20210128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2249.1999.00960.x","article-title":"No association between neutrophil FcgammaRIIa allelic polymorphism and antineutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis","volume":"117","author":"Tse","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"R49-3-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/clim.1999.4811","article-title":"The association of CD18 alleles with antimyeloperoxidase subtypes of ANCA-associated systemic vasculitides","volume":"94","author":"Gencik","year":"2000","journal-title":"Clin Immunol"},{"key":"R50-3-20210128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.gene.6363781","article-title":"Novel SNPs in the CD18 gene validate the association with MPO-ANCA+ vasculitis","volume":"2","author":"Meller","year":"2001","journal-title":"Genes Immun"},{"key":"R51-3-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-5751-4-1","article-title":"Association study with Wegener granulomatosis of the human phospholipase Cgamma2 gene","volume":"4","author":"Jagiello","year":"2005","journal-title":"J Negat Results Biomed"},{"key":"R52-3-20210128","first-page":"781","article-title":"Genetic variability of RXRB, PPARA, and PPARG in Wegeners granulomatosis.","volume":"786","author":"Wieczorek","year":"2009","journal-title":"PPAR Res"},{"key":"R53-3-20210128","first-page":"S72","article-title":"The p53 G72C and MDM2 T309G single nucleotide polymorphisms in patients with Wegener's granulomatosis","volume":"26","author":"Assmann","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"R54-3-20210128","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/ard.2006.065987","article-title":"The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosis","volume":"66","author":"Jenne","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R55-3-20210128","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/rheumatology\/kem099","article-title":"Mannose-binding lectin gene polymorphisms in a cohort study of ANCA-associated small vessel vasculitis","volume":"46","author":"Kamesh","year":"2007","journal-title":"Rheumatology"},{"key":"R57-3-20210128","first-page":"950","article-title":"Coding sequence 1 and promoter single nucleotide polymorphisms in the CTLA-4 gene in Wegener's granulomatosis","volume":"29","author":"Giscombe","year":"2002","journal-title":"J Rheumatol"},{"key":"R58-3-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clim.2008.03.506","article-title":"Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis","volume":"128","author":"Slot","year":"2008","journal-title":"Clin Immunol"},{"key":"R60-3-20210128","first-page":"317","article-title":"Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene","volume":"29","author":"Zhou","year":"2002","journal-title":"J Rheumatol"},{"key":"R61-3-20210128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s001090100263","article-title":"Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis","volume":"79","author":"Murakozy","year":"2001","journal-title":"J Mol Med"},{"key":"R62-3-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1521-6616(03)00211-0","article-title":"Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis","volume":"109","author":"Bartfai","year":"2003","journal-title":"Clin Immunol"},{"key":"R63-3-20210128","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/art.23496","article-title":"Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis","volume":"58","author":"Wieczorek","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R64-3-20210128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2350-10-22","article-title":"Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis [Todd JA, Wong A, Vyse TJ, Kamesh L, Watts RA, Lyons PA, Smith KG.","volume":"10","author":"Carr","year":"2009","journal-title":"BMC Med Genet"},{"key":"R66-3-20210128","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2353\/ajpath.2009.080458","article-title":"Experimental autoimmune vasculitis: an animal model of antineutrophil cytoplasmic autoantibody-associated systemic vasculitis","volume":"174","author":"Little","year":"2009","journal-title":"Am J Pathol"},{"key":"R67-3-20210128","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/ard.2008.097667","article-title":"Thiopurinemethyltransferase (TPMT) genotype and TPMT activity in patients with antineutrophil cytoplasmic antibody-associated vasculitis: relation to azathioprine maintenance treatment and adverse effects","volume":"68","author":"Stassen","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e3283331151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:04:19Z","timestamp":1786039459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201001000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3283331151","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}